RETRACTED: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases
作者:Jiann-Fong Lee、Ting-Yu Chang、Zheng-Fang Liu、Nian-Zhe Lee、Yen-Hsiu Yeh、Yi-Song Chen、Tsung-Chih Chen、Hao-Syun Chou、Tsai-Kun Li、Sung-Bau Lee、Mei-Hsiang Lin
DOI:10.1016/j.ejmech.2020.112074
日期:2020.3
substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory
合成了一系列具有各种取代基的硫代色素[2,3-c]喹啉-12-衍生物,并作为拓扑异构酶(Topo)抑制剂进行了评估。23种化合物中的6种(8、10、12、14、19和26)显示出对Topo介导的DNA松弛和包括乳腺在内的5种人类细胞系(MDA-MB-231,MDA-MB-468和MCF7),大肠癌(HCT116)和非小细胞肺癌(H1299)癌症。其中,化合物14和26对3μM的Topo I和1μM的TopoIIα表现出完全的抑制活性。经过26种处理的癌细胞累积了DNA损伤,被阻滞在G2 / M期。随着时间的流逝,细胞继续凋亡,这表现为DNA碎片化的细胞数量增加以及caspase-8和-9的裂解。相反,正常的乳腺上皮细胞对26的敏感性较低。